You Searched For "covid vaccine price" and got 20 results
Sort By:
2 mins read
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfi…
Kelly Cloonan
3 mins read
AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons
AstraZeneca has announced that the vaccine was being removed from markets for commercial reasons.
ANI
1 min read
Bill Gates says he has to 'have a sense of humor' about vaccine conspiracy theories
Conspiracy theories linking Microsoft cofounder Bill Gates to COVID-19 began to circulate early in …
Beatrice Nolan
2 mins read
Bharat Biotech's nasal Covid vaccine to be priced at ₹800 for private and ₹325 for govt hospitals
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will …
ANI
3 mins read
Singapore seeing new COVID-19 wave, minister advises wearing of masks
The Ministry of Health (MOH) said the estimated number of COVID-19 cases in the week of May 5 t…
PTI
3 mins read
Experts allay fears: It is Covid that triggers heart attacks, not vaccines
There has been a rising spate of heart attacks in India, particularly post Covid-19 pandemic. While…
2 mins read
Covid-19 Nasal vaccine is available on the CoWin portal — here’s how to book your dose
With the surge in Covid-19 cases globally, and this time the BF.7 variant that is said to be highly…
1 min read
Corbevax price slashed to ₹250 per dose inclusive of GST
Vaccine maker Biological E. Ltd (BE) on Monday announced that it has reduced the price of its Covid…
2 mins read
These are the new prices for COVID-19 booster doses as India begins a third shot for adults
Vaccine manufacturers of India announced a major price slash in the COVID-19 vaccine effective from…
1 min read
Moderna extends 2-day gain to 32% after it says Omicron vaccine will be ready in early 2022
"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…
Matthew Fox
1 min read
Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …
Carla Mozée
4 mins read
Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1
The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…
2 mins read
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
1 min read
Rapid COVID-19 tests are reselling for as much as $75 a pack, 3 times their normal retail price: report
Kroger and Walmart sell BinaxNow COVID-19 rapid tests for $23.99 and $19.98 respectively, but some …
Kate Duffy
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
5 mins read
If the COVID-19 vaccine prices are too high for some, then why not use direct benefit transfer
The new prices for COVID-19 vaccine, Covishield, has triggered a debate in India. Some argue that t…
1 min read
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
3 mins read
Adar Poonawalla's Serum cuts Covishield vaccine price for state governments to ₹300 a dose after much backlash
In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…
1 min read
Pfizer extends 5-day gain to record territory as US recommends COVID-19 booster shot
Pfizer cleared a massive resistance level last week when it surged above its record high of $47.39 …
Matthew Fox
2 mins read
Novavax climbs 9% after clinical trial shows the firm's COVID-19 vaccine is 90% effective
The company aims to file for FDA approval of NVX-CoV2373 in the third quarter of 2021 and is contin…